About Dr. Showalter: (bio from HSS Website)
"Dr. Kimberly Showalter is an Assistant Attending Rheumatologist at HSS. She specializes in the care of patients with various rheumatic conditions including systemic sclerosis (scleroderma), systemic lupus erythematosus, rheumatoid arthritis, and others. Dr. Showalter received her Bachelor of Science from the University of Virginia. She attended medical school at Georgetown University where she graduated cum laude. She completed residency training in internal medicine at Northwestern University and her rheumatology fellowship training at HSS. Additionally, she received her master's degree in clinical and translational research from Weill Cornell Medicine. Currently, she conducts clinical and translational research in systemic sclerosis, with a focus on testing novel therapeutics, improving trial outcome measurement tools, and determining predictive patient factors that may assist with personalized disease management. She has received funding and recognition for her research including the Rheumatology Research Foundation Resident Research Preceptorship Award, the Scleroderma Clinical Trials Consortium Young Investigator Award, and the Scleroderma Foundation New Investigator Grant.”
Ms. Aronson discusses her research in Interstitial Lung Disease specific to Scleroderma. In addition to describing current research, Dr. Aronson discusses patient centered outcomes as well as the impact of both medication and non medication based treatments. Clinical trials are also discussed.
About Ms. Aronson:
Ms. Aronson is currently Assistant Professor of Medicine as well as an Assistant Attending Physician at Weil Cornell Medicine in New York City.
Additional professional bio information is pending.
The information presented on this site is intended for educational purposes only. Neither the featured speakers, nor the Scleroderma Foundation, nor Starlight Productions (the producers of these videos) suggest, recommend or endorse any specific treatment for any individual. Patients are advised consult their own health care providers for treatment options. .
[ Return to all Subjects ]